Table 1 Clinicopathological Characteristics of Patients with Node-Positive Endometrioid Uterine Cancer (n=1222)
Parameters | n (%) |
---|---|
Age (years) | |
<65 | 626 (51.2%) |
⩾65 | 596 (48.8%) |
Race | |
White | 1025 (83.9%) |
Black | 75 (6.1%) |
Asian | 91 (7.4%) |
Other | 31 (2.5%) |
Year of diagnosis | |
1988–1992 | 230 (18.8%) |
1993–1997 | 455 (37.2%) |
1998–2001 | 537 (43.9%) |
Stage | |
Stage IIIC | 639 (52.3%) |
Stage IV | 583 (47.7%) |
Stage IVA | 24 (2.0%) |
Stage IVB | 559 (45.7%) |
Grade | |
Grade 1 | 123 (10.0%) |
Grade 2 | 466 (38.1%) |
Grade 3 | 581 (47.5%) |
Unknown | 52 (4.3%) |
Radiation | |
No XRT | 423 (34.6%) |
Adjuvant XRT | 772 (63.2%) |
Unknown | 27 (2.2%) |
Number nodes removed | |
⩽10 | 582 (47.6%) |
11–20 | 320 (26.2%) |
>20 | 320 (26.2%) |
Number of metastatic nodes | |
1 positive node | 529 (43.3%) |
2–5 positive nodes | 547 (44.8%) |
>5 positive nodes | 146 (11.9%) |
Lymph node ratio (%) | |
⩽10 | 306 (25.0%) |
>10–⩽50 | 622 (50.9%) |
>50 | 294 (24.1%) |